This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jap, T.-S. Articles by Won, G.-S. Search for Related Content PubMed PubMed Citation Articles by Jap, T.-S. Articles by Won, G.-S. Pubmed/NCBI databases OMIM Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL

A Novel Mutation in the Calcium-Sensing Receptor Gene in a Chinese Subject with Persistent Hypercalcemia and Hypocalciuria¹

Section of Biochemistry, Department of Pathology and Laboratory Medicine, Division of Endocrinology and Metabolism, Veterans General Hospital–Taipei, School of Medicine, School of Medical Technology and Engineering, National Yang-Ming University, Taipei, Taiwan, ROC.112

Address correspondence and requests for reprints to: Tjin-Shing Jap, M.D., Section of Biochemistry, Department of Pathology and Laboratory Medicine, Veterans General Hospital–Taipei, Taiwan 112. E-mail: tsjap{at}vghtpe.gov.tw

Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant disorder characterized by high penetrance of relatively benign, lifelong persistent hypercalcemia and hypocalciuria. By contrast, neonatal severe hyperparathyroidism represents a life-threatening form of hypercalcemia that can cause the early newborn mortality if immediate intervention is not undertaken. Both disorders are due to inactivation mutation of the human calcium-sensing receptor (CaSR) gene on chromosome 3q21-24. Up to now, more than 30 mutations in the CaSR gene associated with FHH have been described. In this study, we analyzed one 79-yr-old male with hypocalciuric hypercalcemia without siblings or children to compare with an additional group of 50 normal Chinese subjects in Taiwan. DNA sequence analysis of the CaSR gene was performed. The result showed that the proband had a heterozygous nonsense mutation in exon 7 of the CaSR gene at codon 648 (CGATGA/ArgTer). This mutation, located in the COOH-terminal of the first intracellular loop of the CaSR, predicts a markedly truncated protein.

We have identified a novel R648X mutation in the CaSR gene in one patient with FHH in Taiwan

This article has been cited by other articles:

				B. K. Ward, A. L. Magno, E. A. Davis, A. C. Hanyaloglu, B. G. A. Stuckey, M. Burrows, K. A. Eidne, A. K. Charles, and T. Ratajczak Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3721 - 3730. [Abstract] [Full Text] [PDF]